Abnormal liver function test and clinical outcomes
All patient had a serial measurement of AST, ALT, ALP and total serum bilirubin. The upper-recorded values for the recovered patients were compared to the baseline and one day before death values for died patients. The baseline value of total serum bilirubin was higher in died compared to the recovered patients (Mean ± SD,  0.81 ± 0.24  versus 0.63 ± 0.36; p=0.001), whereas AST, ALT, and ALP were not significantly differed between both group (Mean ± SD,  23.09 ± 9.69 versus 21.87 ± 12.04; p=0.436), (Mean ± SD,  29.65 ± 20.49 versus 27.46 ± 10.37; p=0.476), and (Mean ± SD,  100.85 ± 68.01 versus 104.57 ± 46.65; p=0.719), respectively (Table 4).
Comparing to recovered patients, the entire liver function test one day before death were high in died patients {AST (Mean ± SD,  36.98 ± 10.92 versus 23.09 ± 9.69; p=0.000); ALT (Mean ± SD,  40.28 ± 12.92 versus 29.65 ± 20.49; p=0.000); ALP (Mean ± SD,  122.35 ± 40.43 versus 100.85 ± 68.01; p=0.037) and total bilirubin, (Mean ± SD,  1.36 ± 0.96 versus 0.63 ± 0.36; p=0.000)}. Furthermore, for died patients, the AST, ALT, and total bilirubin one day before death was significantly higher comparing to their baseline value [AST,  (Mean ± SD,  36.98 ± 10.92 versus 21.87 ± 12.04; p=0.000); ALT (Mean ± SD,  40.28 ± 12.92 versus 27.46 ± 10.37; p=0.000); and total bilirubin, (Mean ± SD,  1.36 ± 0.96 versus 0.81 ± 0.24; p=0.000)] (Table 4, Fig. 2).